Last reviewed · How we verify
Prefilled Syringe delivery of Golimumab — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Prefilled Syringe delivery of Golimumab (Prefilled Syringe delivery of Golimumab) — Merck Sharp & Dohme LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Prefilled Syringe delivery of Golimumab TARGET | Prefilled Syringe delivery of Golimumab | Merck Sharp & Dohme LLC | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Prefilled Syringe delivery of Golimumab CI watch — RSS
- Prefilled Syringe delivery of Golimumab CI watch — Atom
- Prefilled Syringe delivery of Golimumab CI watch — JSON
- Prefilled Syringe delivery of Golimumab alone — RSS
Cite this brief
Drug Landscape (2026). Prefilled Syringe delivery of Golimumab — Competitive Intelligence Brief. https://druglandscape.com/ci/prefilled-syringe-delivery-of-golimumab. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab